Cargando…
Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data
We demonstrate that prostate cancer can be identified by flow cytometric profiling of blood immune cell subsets. Herein, we profiled natural killer (NK) cell subsets in the blood of 72 asymptomatic men with Prostate-Specific Antigen (PSA) levels < 20 ng ml(-1), of whom 31 had benign disease (no c...
Autores principales: | Hood, Simon P, Cosma, Georgina, Foulds, Gemma A, Johnson, Catherine, Reeder, Stephen, McArdle, Stéphanie E, Khan, Masood A, Pockley, A Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386909/ https://www.ncbi.nlm.nih.gov/pubmed/32717179 http://dx.doi.org/10.7554/eLife.50936 |
Ejemplares similares
-
Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml(−1) Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
por: Cosma, Georgina, et al.
Publicado: (2017) -
Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
por: Cosma, Georgina, et al.
Publicado: (2021) -
Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation
por: Hood, Simon P., et al.
Publicado: (2019) -
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
por: Foulds, Gemma A., et al.
Publicado: (2018) -
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
por: Shackleton, Erin G., et al.
Publicado: (2021)